Ditchcarbon
  • Customers
  1. Organizations
  2. Tissue Genesis, Inc.
Public Profile
Research Services
US
updated 5 months ago

Tissue Genesis, Inc.

Company website

Tissue Genesis, Inc., a pioneering entity in the regenerative medicine sector, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development of innovative tissue engineering solutions, particularly in the fields of cellular therapies and regenerative medicine. With a focus on harnessing the potential of adipose-derived stem cells, Tissue Genesis offers unique products and services that facilitate advanced healing and tissue regeneration. Their proprietary technologies are designed to enhance patient outcomes in various medical applications, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, Tissue Genesis continues to expand its operational reach, contributing significantly to the advancement of regenerative therapies and solidifying its position as a key player in the industry.

DitchCarbon Score

How does Tissue Genesis, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Tissue Genesis, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

36%

Let us know if this data was useful to you

Tissue Genesis, Inc.'s reported carbon emissions

Tissue Genesis, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Tissue Genesis, Inc. may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tissue Genesis, Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Tissue Genesis, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tissue Genesis, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lineage Cell Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Celgene Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Regenerative Sciences, Inc.

US
•
Insurance and pension funding services, except compulsory social security services (66)
Updated 13 days ago

XCell-Center

DE
Updated 13 days ago

Plus Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy